• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎暴发性心肌炎:一例报告

COVID-19 fulminant myocarditis: a case report.

作者信息

Bernal-Torres Wikler, Herrera-Escandón Álvaro, Hurtado-Rivera Manuel, Plata-Mosquera Carlos Andrés

机构信息

Clinica DIME neurocardiovascular, Calle 4d Numero 89-36, Cali 760034, Colombia.

出版信息

Eur Heart J Case Rep. 2020 Jul 8;4(FI1):1-6. doi: 10.1093/ehjcr/ytaa212. eCollection 2020 Oct.

DOI:10.1093/ehjcr/ytaa212
PMID:33089053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7454494/
Abstract

BACKGROUND

Fulminant myocarditis is a catastrophic disease with high mortality and complications. A viral aetiology is frequent and the implication of SARS-CoV-2 is not yet known.

CASE SUMMARY

A 38-year-old woman who recently arrived from Spain presented with palpitations that started suddenly 3 days prior to presentation and were associated with haemodynamic instability, without dyspnoea or chest pain. We found features of myopericarditis on the electrocardiogram and severe systolic dysfunction on the echocardiogram. The chest tomography showed findings which suggested COVID-19 infection, and PCR for SARS-CoV-2 was positive. The cardiac magnetic resonance image showed Lake Louise criteria for myocarditis. The patient was treated with immunomodulatory, steroid, and immunoglobulin therapy, with a favourable clinical response.

DISCUSSION

The importance of this case lies in highlighting the severe cardiac involvement in a young patient, without previous risk factors, positive for COVID-19, and the favourable response to the medical treatment given.

摘要

背景

暴发性心肌炎是一种具有高死亡率和并发症的灾难性疾病。病毒病因常见,而严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的影响尚不清楚。

病例摘要

一名38岁女性,近期从西班牙抵达,就诊前3天突然出现心悸,并伴有血流动力学不稳定,无呼吸困难或胸痛。我们在心电图上发现了心肌心包炎的特征,在超声心动图上发现了严重的收缩功能障碍。胸部断层扫描显示提示新型冠状病毒肺炎(COVID-19)感染的表现,SARS-CoV-2的聚合酶链反应(PCR)呈阳性。心脏磁共振成像显示符合心肌炎的路易斯湖标准。该患者接受了免疫调节、类固醇和免疫球蛋白治疗,临床反应良好。

讨论

该病例的重要性在于突出了一名无既往危险因素、COVID-19检测呈阳性的年轻患者出现的严重心脏受累情况,以及对所给予的药物治疗的良好反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3f3/7566521/676067775ed2/ytaa212f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3f3/7566521/01fc5589d4d2/ytaa212f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3f3/7566521/bb982a5adad8/ytaa212f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3f3/7566521/63f3453710f5/ytaa212f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3f3/7566521/d902a04755b3/ytaa212f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3f3/7566521/676067775ed2/ytaa212f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3f3/7566521/01fc5589d4d2/ytaa212f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3f3/7566521/bb982a5adad8/ytaa212f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3f3/7566521/63f3453710f5/ytaa212f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3f3/7566521/d902a04755b3/ytaa212f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3f3/7566521/676067775ed2/ytaa212f5.jpg

相似文献

1
COVID-19 fulminant myocarditis: a case report.新型冠状病毒肺炎暴发性心肌炎:一例报告
Eur Heart J Case Rep. 2020 Jul 8;4(FI1):1-6. doi: 10.1093/ehjcr/ytaa212. eCollection 2020 Oct.
2
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).新冠肺炎(COVID-19)患者的心脏受累。
JAMA Cardiol. 2020 Jul 1;5(7):819-824. doi: 10.1001/jamacardio.2020.1096.
3
COVID-19 Associated Fulminant Myocarditis in a Fully-Vaccinated Female: A Case Report with Clinical Follow-up.一名全程接种疫苗的女性患者发生的新型冠状病毒肺炎相关暴发性心肌炎:病例报告及临床随访
Clin Med Insights Case Rep. 2023 Feb 8;16:11795476221147238. doi: 10.1177/11795476221147238. eCollection 2023.
4
A Case of Isolated SARS-CoV-2 Fulminant Myopericarditis Without Respiratory Failure.一例无呼吸衰竭的孤立性严重急性呼吸综合征冠状病毒2型暴发性心肌心包炎病例。
Cureus. 2021 Mar 19;13(3):e14003. doi: 10.7759/cureus.14003.
5
Acute myocarditis related to Covid-19 infection: 2 cases report.新型冠状病毒肺炎感染相关急性心肌炎:2例报告
Ann Med Surg (Lond). 2021 Jun;66:102431. doi: 10.1016/j.amsu.2021.102431. Epub 2021 May 26.
6
Management of COVID-19 myopericarditis with reversal of cardiac dysfunction after blunting of cytokine storm: a case report.细胞因子风暴平息后心脏功能障碍逆转的COVID-19心肌炎管理:一例报告
Eur Heart J Case Rep. 2020 Jul 21;4(FI1):1-6. doi: 10.1093/ehjcr/ytaa224. eCollection 2020 Oct.
7
Fulminant myocarditis in a COVID-19 positive patient treated with mechanical circulatory support - a case report.1例COVID-19阳性患者发生暴发性心肌炎并接受机械循环支持治疗——病例报告
Eur Heart J Case Rep. 2020 Dec 30;5(2):ytaa523. doi: 10.1093/ehjcr/ytaa523. eCollection 2021 Feb.
8
COVID-19 Myopericarditis in a Young Healthy Male.一名年轻健康男性的新冠病毒感染相关心肌心包炎
Eur J Case Rep Intern Med. 2022 May 23;9(5):003361. doi: 10.12890/2022_003361. eCollection 2022.
9
Coronavirus (COVID-19) Fulminant Myopericarditis and Acute Respiratory Distress Syndrome (ARDS) in a Middle-Aged Male Patient.一名中年男性患者的冠状病毒(COVID-19)暴发性心肌炎和急性呼吸窘迫综合征(ARDS)
Cureus. 2020 Jun 24;12(6):e8808. doi: 10.7759/cureus.8808.
10
Coronavirus disease 2019 (Covid-19) presenting as purulent fulminant myopericarditis and cardiac tamponade: A case report and literature review.2019 年冠状病毒病(COVID-19)表现为脓性暴发性心肌炎和心脏压塞:病例报告及文献复习。
Heart Lung. 2020 Nov-Dec;49(6):858-863. doi: 10.1016/j.hrtlng.2020.06.003. Epub 2020 Jun 9.

引用本文的文献

1
Clinical characteristics, diagnosis and short-term outcomes of COVID-19-associated acute myocarditis in China.中国新型冠状病毒肺炎相关急性心肌炎的临床特征、诊断及短期预后
ESC Heart Fail. 2025 Feb;12(1):338-352. doi: 10.1002/ehf2.15048. Epub 2024 Sep 19.
2
Fulminant Myocarditis with SARS-CoV-2 Infection: A Narrative Review from the Case Studies.新型冠状病毒2型感染所致暴发性心肌炎:病例研究的叙述性综述
Can J Infect Dis Med Microbiol. 2024 Mar 4;2024:9000598. doi: 10.1155/2024/9000598. eCollection 2024.
3
Clinical outcome of established diagnostic and treatment modalities of COVID-19-associated myocarditis: a systematic review.

本文引用的文献

1
Myocardial injury and COVID-19: Possible mechanisms.心肌损伤与 COVID-19:可能的机制。
Life Sci. 2020 Jul 15;253:117723. doi: 10.1016/j.lfs.2020.117723. Epub 2020 Apr 28.
2
Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China.新型冠状病毒肺炎患者疑似心肌损伤:来自中国武汉一线临床观察的证据。
Int J Cardiol. 2020 Jul 15;311:116-121. doi: 10.1016/j.ijcard.2020.03.087. Epub 2020 Apr 8.
3
Myocardial localization of coronavirus in COVID-19 cardiogenic shock.COVID-19 心原性休克中冠状病毒的心肌定位。
新型冠状病毒肺炎相关心肌炎既定诊断和治疗方式的临床结局:一项系统评价
Ann Med Surg (Lond). 2023 Jun 16;85(7):3583-3594. doi: 10.1097/MS9.0000000000000964. eCollection 2023 Jul.
4
Fulminant Myocarditis and Cardiogenic Shock Following COVID-19 Infection Versus COVID-19 Vaccination: A Systematic Literature Review.新型冠状病毒感染与新冠疫苗接种后暴发性心肌炎和心源性休克:一项系统文献综述
J Clin Med. 2023 Feb 25;12(5):1849. doi: 10.3390/jcm12051849.
5
SARS-CoV-2 dilated cardiomyopathy.严重急性呼吸综合征冠状病毒2型扩张型心肌病
Br J Cardiol. 2022 Aug 30;29(3):30. doi: 10.5837/bjc.2022.030. eCollection 2022.
6
Cardiovascular Complications in Kidney Transplant Recipients with COVID-19: A Case Series.新冠病毒肺炎肾移植受者的心血管并发症:病例系列
Indian J Nephrol. 2022 Sep-Oct;32(5):506-511. doi: 10.4103/ijn.ijn_503_21. Epub 2022 Jul 2.
7
First report of myocarditis in two patients with COVID-19 Omicron variant: case report.两例感染新冠病毒奥密克戎变异株患者发生心肌炎的首例报告:病例报告
Eur Heart J Case Rep. 2022 Oct 5;6(10):ytac407. doi: 10.1093/ehjcr/ytac407. eCollection 2022 Oct.
8
COVID-19 Related Myocarditis in Adults: A Systematic Review of Case Reports.成人 COVID-19 相关心肌炎:病例报告的系统评价
J Clin Med. 2022 Sep 21;11(19):5519. doi: 10.3390/jcm11195519.
9
Cardiovascular Damage in COVID-19: What We Know Two Years Later.COVID-19 相关心血管损伤:两年后的认识。
Curr Cardiol Rep. 2022 Sep;24(9):1085-1091. doi: 10.1007/s11886-022-01730-4. Epub 2022 Jun 25.
10
Comorbidities and Symptomatology of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2)-Related Myocarditis and SARS-CoV-2 Vaccine-Related Myocarditis: A Review.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)相关心肌炎和SARS-CoV-2疫苗相关心肌炎的合并症与症状学:综述
Cureus. 2022 Apr 12;14(4):e24084. doi: 10.7759/cureus.24084. eCollection 2022 Apr.
Eur J Heart Fail. 2020 May;22(5):911-915. doi: 10.1002/ejhf.1828. Epub 2020 Apr 11.
4
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).新冠肺炎(COVID-19)患者的心脏受累。
JAMA Cardiol. 2020 Jul 1;5(7):819-824. doi: 10.1001/jamacardio.2020.1096.
5
Clinical and immunological features of severe and moderate coronavirus disease 2019.新型冠状病毒病 2019 重症和中度患者的临床和免疫学特征。
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.
6
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19:一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
7
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.洛匹那韦-利托那韦治疗成人重症 COVID-19 患者的临床试验。
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
8
Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin.糖皮质激素联合人免疫球蛋白治疗冠状病毒暴发性心肌炎
Eur Heart J. 2021 Jan 7;42(2):206. doi: 10.1093/eurheartj/ehaa190.
9
Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis.2019冠状病毒病(COVID-19)患者的心肌肌钙蛋白I:一项荟萃分析的证据
Prog Cardiovasc Dis. 2020 May-Jun;63(3):390-391. doi: 10.1016/j.pcad.2020.03.001. Epub 2020 Mar 10.
10
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.